SlideShare ist ein Scribd-Unternehmen logo
1 von 36
ADVERSE DRUG REACTIONS
DEFINATIONS
Adverse drug reactions (WHO):
Any response to a drug that is noxious and unintended
and that occurs at doses used in man for prophylaxis,
diagnosis or therapy of disease or modification of
physiological states.
No Drugs are
Dangerous if
used properly

All Drugs are
Dangerous

Some drugs
have a low
therapeutic ratio

Some drugs have a
low incidence of
horrendous effects

Some drugs are
dangerous in
acute poisoning
but not when
used
therapeutically

The most
dangerous drugs
have the greatest
potential for
benefit

Some adverse
effects occur
after a delay or
after stopping

BAD

GOOD

How dangerous a drug is
depends on the skill of the
prescriber

Some adverse
effects can be
predicted if you
know the
pharmacology
(Type A); some
are not (Type B)
The Risk to Benefit Ratio
When prescribing drugs a doctor must assess
risk to benefit ratio in the individual patient by
‱Choosing an appropriate class of drug then an
appropriate individual agent
RISK

BENEFIT

‱Is it effective ?
‱What are the chances of adverse effect ?
‱Are there features in this patient which
affect choice eg other drugs, organ failure,
aged
‱Tailoring the dose
‱Considering duration of treatment
Epidemiology
4% of hospital admissions
1 in 1000 deaths in medical wards
10 to 20 % of in-patients
5% of patients in general practice
More frequent in elderly:
erratic drug taking
multiple pathology
altered pharmacokinetics
increased sensitivity of CNS
and CVS
Drugs - anti-coagulants,
NSAIDs,corticosteroids, antihypertensives, anti-biotics, diuretics
and insulin.
Occur in circumstances related to
drug’s pharmacology, predisposing
factors in the patient and care taken
in choosing the drug and the dose.
SIDE EFFECTS Pharmacological effects produced with therapeutic dose of drug.
 Troublesome in one condition but useful in others.
 Ex. atropine

UNTOWARD EFFECTS Undesirable effects with therapeutic dose of the drug ,if severe requires
caessation of treatment.
 Ex.tetracyclines,aspirin

TOXIC EFFECTS Effects produced by large & / repeated doses
 Ex. morphine
ADR

TYPES

QUANTITATIVE

QUALITATIVE

(Type A)

(Type B)

IDIOSYNCRASY
Genetic

ALLERGY
Unknown

I

II

III

(HYPERSENSITIVITY)

IV
Comparison –type A &B
Type A

Type B

1.Nature

augmented/ attenuated normal Totally abnormal, bizarre
response

2.Mechanism

Hyper/ hypo response

Genetic, immunological,UK

3. Predictable

Yes

No

4.Incidence

high

Low

5.Mortality

Low

High

6. Treatment

Adjust dose

Stop the drug

7.Dose dependent

Yes

No
IDIOSYNCRASY
GENETIC
‱ G6PD DEFECIENCY
‱ ATYPICAL PSEUDOCHOLINESTRASES
UNKNOWN
Chloramphenicol –Aplastic anaemia
ALLERGIC REACTION
FEATURES
1. Ranges from mild- severe (anaphylaxis)
2. Prior sensitization requried
3. Immunologically mediated
4. Low incidence , unpredictable, dose
independent.
Hypersensitivity
Hypersensitivity is an immune reaction to
innocuous antigens that results in tissue injury
and/or disease
An antigen that causes allergy is an allergen
TYPES OF ALLERGIC REACTIONS
I.IgE MEDIATED REACTION AND
ANAPHYLAXIS-(immediate hypersensitivity)
‱ Systemic anaphylaxis- ex.penicillin.
Antigen + IgE antibodies—influx of ca++ ----degranulation of mast
cells ,basophiles—release of histamine---anaphylaxis
‱ Local anaphylaxis -Hay fever
-Asthma
-Diarrhea, gi.Pain.
-Skin rash
Allergy (type I hypersensitivity mediated
by IgE on mast cells)
Mast cell degranulation by antigen (allergen)
cross-linking of FceR-bound IgE
Mast cell activation has many effects
TYPE II ALLRGIC REACTION
Cytotoxic type reactionAntibodies binds to antigen present on the cell surface
promotes phagocytosis of cell or cell destruction by
polymorphs, macrophages or by lymphoid killer cells.
ExamplesTransfusion reactions
Rh incompatibility
‱ drugs-antigenic complex with blood cells----increase
humoral antibodies----cytotoxic –
haemolysis / agranulocytosis / thrombocytopenia
Type II hypersensitivity (IgG-mediated anticell-associated antigen response) is rare
Immune response to certain drugs (e.g.,
penicillin) where drug binds to cell surface and
antibody cause removal of the cells (usually
by macrophages).
TYPE III
IMMUNE COMPLEX MEDIATED REACTIONS
ANTIGEN+HUMORAL ANTIBODIES
IMMUNE COMPLEXES
Ab EXCESS
Ppt.NEAR SITE OF ENTRY
SKIN-ERYTHEMA,EDEMA, ETC.
ARTHUS REACTION

Ag EXCESS
DEPOSIT IN SKIN, JOINTS
KIDNEY
SERUM SICKNESS
Arthus Reaction: acute antibodymediated hypersensitivity to soluble
antigens
TYPE IV
CELL MEDIATED REACTION-(Delayed hypersensitivity)
 Inflammatory reaction initiated by T cells.
 Delayed-secondary cellular response occurs after 48
hrs of antigen exposure.
 Examples1.montoux reaction-i.d. tuberculin inj.
2.Sulphonamides
Four Types of Hypersensitivities
MANIFESTATION OF ADR
1. Haemopoetic toxicity
2. Hepatotoxicity –direct / immunological
3. Nephrotoxicity
4. Abnormality in taste & smell
5. Occular toxicity
6. Ototoxicity
7. Behavioural toxicity
8. Iatrogenic diseases
9.Teratogenicity
Risk Factors for Adverse Drug Reactions
Simultaneous use of several different drugs
– Drug-drug interactions

Very young, or very old in age
Pregnancy
Breast Feeding
Hereditary Factors
Disease states which may effect drug absorption,
metabolism, and/or elimination
32
Risk Factors Examples: Simultaneous Drug Use or
Drug-Drug Interactions
Cerivastatin-Gemfibrozil interactions in
hypercholesterolemia patients (rhabdomyolysis)
Coumadin-NSAID interactions (increased inhibition of
platelet aggregation)
Venlafaxine-indinavir interactions in depressed HIVinfected patients (decreased indinavir concentrations)
33
Risk Factors Examples: Age Related Issues
Children are often at risk because their capacity to
metabolize drugs is usually not fully developed
– Newborns cannot metabolize or eliminate chloramphenicol, an
antibiotic
– Children younger than 18 may be at risk of developing Reye’s
syndrome if given acetylsalicylic acid (aspirin) while infected with
chickenpox or influenza
– Central nervous system effects of topiramate in children
(seizures, tremor, and dizziness)
34
Risk Factors Examples: Age Related
Issues
ïŹ ADRs, including drug interactions, are a common cause of

admission to hospitals in the elderly
ïŹ Reasons for ADRs in the elderly:
– Concomitant use of several medications
– Disease states leading to drug ADME changes
– Decreased drug ADME activity due to age

ïŹ These conditions are exacerbated by malnutrition and

dehydration, common in the elderly
35
Risk Factors Examples: Pregnancy
ïŹ Use of sulfonamides (antibiotic) can lead to

jaundice and brain damage in the fetus
ïŹ Warfarin use for anticoagulation can lead to birth
defects, and increased risk of bleeding problems in
newborns and mothers
ïŹ Lithium, for bipolar disorder, can lead to defects of
the heart, lethargy, reduced muscle tone, and
underactivity of the thyroid gland
36
Risk Factors Examples: Breastfeeding
ïŹ Similar concerns, as for other children with

underdeveloped capability to metabolize or excrete
xenobiotics
ïŹ Many drugs can be passed from mother to infant
via breast milk
– Amantadine (antiviral)
– Cyclophosphamide (antineoplastic)
– Cocaine (Schedule 2 FDA drug)
– Carisoprodol (skeletal muscle relaxant)

37
Risk Factors Examples: Hereditary
Factors
ïŹ Genetic polymorphisms may play a role
– Evident in CYP2C9 and 2C19, especially in the Asian population

(phenytoin)
– May lead to impaired metabolism in mutation of enzymes
ïŹ Higher risk of hemolysis in some populations, such as

African, Middle Eastern, and South East Asian races
– Quinolones
– Antimalarials
38
Risk Factors Examples: Disease States
ïŹ Metabolism (Phase I or II) may be impaired with

hepatic disease
– Cirrhosis
– Hepatic Carcinoma

ïŹ Renal Insufficiency
– Acute or Chronic Renal Failure
– Decreased glomerular filtration rate (GFR)

ïŹ Drug levels may become toxic if too high, so

dosing modifications may be indicated

39

Weitere Àhnliche Inhalte

Was ist angesagt?

Pharmaceutical care
Pharmaceutical carePharmaceutical care
Pharmaceutical care
Akram Ahmad
 
Clinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationClinical pharmacokinetics and its application
Clinical pharmacokinetics and its application
pavithra vinayak
 

Was ist angesagt? (20)

Drug information center
Drug  information centerDrug  information center
Drug information center
 
Clinical pharmacy
Clinical pharmacyClinical pharmacy
Clinical pharmacy
 
Adverse drug reactions and drug interactions
Adverse drug reactions and drug interactionsAdverse drug reactions and drug interactions
Adverse drug reactions and drug interactions
 
Drug Therapy Monitiring
Drug Therapy MonitiringDrug Therapy Monitiring
Drug Therapy Monitiring
 
ADR AND ITS MONITORING
ADR  AND  ITS MONITORING ADR  AND  ITS MONITORING
ADR AND ITS MONITORING
 
Effects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokineticsEffects of liver diseases on pharmacokinetics
Effects of liver diseases on pharmacokinetics
 
Adverse drug reaction ppt
Adverse drug reaction pptAdverse drug reaction ppt
Adverse drug reaction ppt
 
Therapeutic drug monitoring (TDM) of drugs used in seizure disorders
Therapeutic drug monitoring (TDM) of drugs used in seizure disordersTherapeutic drug monitoring (TDM) of drugs used in seizure disorders
Therapeutic drug monitoring (TDM) of drugs used in seizure disorders
 
Pharmacovigilence
PharmacovigilencePharmacovigilence
Pharmacovigilence
 
Drug information and poison information
Drug information and poison informationDrug information and poison information
Drug information and poison information
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Pharmaceutical care
Pharmaceutical carePharmaceutical care
Pharmaceutical care
 
Cassualty assesment of adr
Cassualty assesment of adrCassualty assesment of adr
Cassualty assesment of adr
 
Drug distribution in hospital pharmacy
Drug distribution in hospital pharmacyDrug distribution in hospital pharmacy
Drug distribution in hospital pharmacy
 
Patient Information Leafelet
Patient Information LeafeletPatient Information Leafelet
Patient Information Leafelet
 
Adverse drug reactions ppt
Adverse drug reactions pptAdverse drug reactions ppt
Adverse drug reactions ppt
 
Dose adjustment in Renal Disorders
Dose adjustment in Renal DisordersDose adjustment in Renal Disorders
Dose adjustment in Renal Disorders
 
Pharmaceutical care
Pharmaceutical carePharmaceutical care
Pharmaceutical care
 
Drug Information Services
Drug Information ServicesDrug Information Services
Drug Information Services
 
Clinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationClinical pharmacokinetics and its application
Clinical pharmacokinetics and its application
 

Andere mochten auch (11)

Adverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & ReportingAdverse Drug Reactions - Identifying, Causality & Reporting
Adverse Drug Reactions - Identifying, Causality & Reporting
 
Drug and the hypersensitivity reactions
Drug and the hypersensitivity reactionsDrug and the hypersensitivity reactions
Drug and the hypersensitivity reactions
 
Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reaction
 
Introduction to Adverse Drug Reactions
Introduction to Adverse Drug ReactionsIntroduction to Adverse Drug Reactions
Introduction to Adverse Drug Reactions
 
Adverse Drug Reactions
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug Reactions
 
Adverse drugeffects
Adverse drugeffectsAdverse drugeffects
Adverse drugeffects
 
Adverse drug reactions
Adverse drug  reactionsAdverse drug  reactions
Adverse drug reactions
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Adverse Drug Reactions
Adverse Drug ReactionsAdverse Drug Reactions
Adverse Drug Reactions
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Clinical patterns of adverse drug reactions ppt
Clinical patterns of adverse drug reactions pptClinical patterns of adverse drug reactions ppt
Clinical patterns of adverse drug reactions ppt
 

Ähnlich wie ADRs (VK)

pharmacovigilance- clinical pharmacy pharm-D
pharmacovigilance- clinical pharmacy pharm-Dpharmacovigilance- clinical pharmacy pharm-D
pharmacovigilance- clinical pharmacy pharm-D
Anusha Are
 

Ähnlich wie ADRs (VK) (20)

Adverse drug reaction
Adverse   drug  reactionAdverse   drug  reaction
Adverse drug reaction
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Adverse drug reactions.pptx
Adverse drug reactions.pptxAdverse drug reactions.pptx
Adverse drug reactions.pptx
 
Adr
AdrAdr
Adr
 
06 CHAPTER.pptx
06 CHAPTER.pptx06 CHAPTER.pptx
06 CHAPTER.pptx
 
pharmacovigilance- clinical pharmacy pharm-D
pharmacovigilance- clinical pharmacy pharm-Dpharmacovigilance- clinical pharmacy pharm-D
pharmacovigilance- clinical pharmacy pharm-D
 
Carcinogenesis
Carcinogenesis Carcinogenesis
Carcinogenesis
 
5.ppt
5.ppt5.ppt
5.ppt
 
ADRs.ppt
ADRs.pptADRs.ppt
ADRs.ppt
 
adr ppt (2).ppt
adr ppt (2).pptadr ppt (2).ppt
adr ppt (2).ppt
 
Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reaction
 
Adverse drug reaction and reporting
Adverse drug reaction and reportingAdverse drug reaction and reporting
Adverse drug reaction and reporting
 
Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reaction
 
ADR
ADR ADR
ADR
 
Adverse drug monitoring
Adverse drug monitoringAdverse drug monitoring
Adverse drug monitoring
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Adverse drug reactions
Adverse drug reactionsAdverse drug reactions
Adverse drug reactions
 
Adverse Drug Reaction - Pharmacology
Adverse Drug Reaction - PharmacologyAdverse Drug Reaction - Pharmacology
Adverse Drug Reaction - Pharmacology
 
Adverse drug reaction
Adverse drug reactionAdverse drug reaction
Adverse drug reaction
 
adverse drug reaction.ppt
adverse drug reaction.pptadverse drug reaction.ppt
adverse drug reaction.ppt
 

Mehr von Dr. Abhavathi Vijay Kumar (20)

Immunomodulators(VK)
Immunomodulators(VK)Immunomodulators(VK)
Immunomodulators(VK)
 
Adrenergic drugs (VK)
Adrenergic drugs (VK)Adrenergic drugs (VK)
Adrenergic drugs (VK)
 
Antianginal drugs (VK)
Antianginal drugs (VK)Antianginal drugs (VK)
Antianginal drugs (VK)
 
Sulfonamides (VK)
Sulfonamides (VK)Sulfonamides (VK)
Sulfonamides (VK)
 
RHEUMATOID ARTHRITIS (VK)
RHEUMATOID ARTHRITIS (VK)RHEUMATOID ARTHRITIS (VK)
RHEUMATOID ARTHRITIS (VK)
 
Penicillins (VK)
Penicillins (VK)Penicillins (VK)
Penicillins (VK)
 
Opioid analgesics (VK)
Opioid analgesics (VK)Opioid analgesics (VK)
Opioid analgesics (VK)
 
NSAIDs (VK)
NSAIDs (VK)NSAIDs (VK)
NSAIDs (VK)
 
Migraine (VK)
Migraine (VK)Migraine (VK)
Migraine (VK)
 
Local anesthetics (VK)
Local anesthetics (VK)Local anesthetics (VK)
Local anesthetics (VK)
 
General anesthetics(VK)
General anesthetics(VK)General anesthetics(VK)
General anesthetics(VK)
 
Excretion of drug (VK)
Excretion of drug (VK)Excretion of drug (VK)
Excretion of drug (VK)
 
Emetics and antiemetics(VK)
Emetics and antiemetics(VK)Emetics and antiemetics(VK)
Emetics and antiemetics(VK)
 
Cough (VK)
Cough (VK)Cough (VK)
Cough (VK)
 
Chelating agents (VK)
Chelating agents (VK)Chelating agents (VK)
Chelating agents (VK)
 
Bipolar Disorder (VK)
Bipolar Disorder (VK)Bipolar Disorder (VK)
Bipolar Disorder (VK)
 
Blood (VK)
Blood (VK)Blood (VK)
Blood (VK)
 
Antiplatelet drugs (VK)
Antiplatelet drugs (VK)Antiplatelet drugs (VK)
Antiplatelet drugs (VK)
 
Anticoagulants (VK)
Anticoagulants (VK)Anticoagulants (VK)
Anticoagulants (VK)
 
Antimalarial drugs (VK)
Antimalarial drugs (VK)Antimalarial drugs (VK)
Antimalarial drugs (VK)
 

KĂŒrzlich hochgeladen

1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdfVishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
ssuserdda66b
 

KĂŒrzlich hochgeladen (20)

SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdfVishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
 

ADRs (VK)

  • 2. DEFINATIONS Adverse drug reactions (WHO): Any response to a drug that is noxious and unintended and that occurs at doses used in man for prophylaxis, diagnosis or therapy of disease or modification of physiological states.
  • 3. No Drugs are Dangerous if used properly All Drugs are Dangerous Some drugs have a low therapeutic ratio Some drugs have a low incidence of horrendous effects Some drugs are dangerous in acute poisoning but not when used therapeutically The most dangerous drugs have the greatest potential for benefit Some adverse effects occur after a delay or after stopping BAD GOOD How dangerous a drug is depends on the skill of the prescriber Some adverse effects can be predicted if you know the pharmacology (Type A); some are not (Type B)
  • 4. The Risk to Benefit Ratio When prescribing drugs a doctor must assess risk to benefit ratio in the individual patient by ‱Choosing an appropriate class of drug then an appropriate individual agent RISK BENEFIT ‱Is it effective ? ‱What are the chances of adverse effect ? ‱Are there features in this patient which affect choice eg other drugs, organ failure, aged ‱Tailoring the dose ‱Considering duration of treatment
  • 5. Epidemiology 4% of hospital admissions 1 in 1000 deaths in medical wards 10 to 20 % of in-patients 5% of patients in general practice
  • 6. More frequent in elderly: erratic drug taking multiple pathology altered pharmacokinetics increased sensitivity of CNS and CVS
  • 7. Drugs - anti-coagulants, NSAIDs,corticosteroids, antihypertensives, anti-biotics, diuretics and insulin.
  • 8. Occur in circumstances related to drug’s pharmacology, predisposing factors in the patient and care taken in choosing the drug and the dose.
  • 9.
  • 10.
  • 11.
  • 12. SIDE EFFECTS Pharmacological effects produced with therapeutic dose of drug.  Troublesome in one condition but useful in others.  Ex. atropine UNTOWARD EFFECTS Undesirable effects with therapeutic dose of the drug ,if severe requires caessation of treatment.  Ex.tetracyclines,aspirin TOXIC EFFECTS Effects produced by large & / repeated doses  Ex. morphine
  • 14. Comparison –type A &B Type A Type B 1.Nature augmented/ attenuated normal Totally abnormal, bizarre response 2.Mechanism Hyper/ hypo response Genetic, immunological,UK 3. Predictable Yes No 4.Incidence high Low 5.Mortality Low High 6. Treatment Adjust dose Stop the drug 7.Dose dependent Yes No
  • 15. IDIOSYNCRASY GENETIC ‱ G6PD DEFECIENCY ‱ ATYPICAL PSEUDOCHOLINESTRASES UNKNOWN Chloramphenicol –Aplastic anaemia
  • 16. ALLERGIC REACTION FEATURES 1. Ranges from mild- severe (anaphylaxis) 2. Prior sensitization requried 3. Immunologically mediated 4. Low incidence , unpredictable, dose independent.
  • 17. Hypersensitivity Hypersensitivity is an immune reaction to innocuous antigens that results in tissue injury and/or disease An antigen that causes allergy is an allergen
  • 18. TYPES OF ALLERGIC REACTIONS I.IgE MEDIATED REACTION AND ANAPHYLAXIS-(immediate hypersensitivity) ‱ Systemic anaphylaxis- ex.penicillin. Antigen + IgE antibodies—influx of ca++ ----degranulation of mast cells ,basophiles—release of histamine---anaphylaxis ‱ Local anaphylaxis -Hay fever -Asthma -Diarrhea, gi.Pain. -Skin rash
  • 19. Allergy (type I hypersensitivity mediated by IgE on mast cells)
  • 20. Mast cell degranulation by antigen (allergen) cross-linking of FceR-bound IgE
  • 21. Mast cell activation has many effects
  • 22. TYPE II ALLRGIC REACTION Cytotoxic type reactionAntibodies binds to antigen present on the cell surface promotes phagocytosis of cell or cell destruction by polymorphs, macrophages or by lymphoid killer cells. ExamplesTransfusion reactions Rh incompatibility ‱ drugs-antigenic complex with blood cells----increase humoral antibodies----cytotoxic – haemolysis / agranulocytosis / thrombocytopenia
  • 23. Type II hypersensitivity (IgG-mediated anticell-associated antigen response) is rare Immune response to certain drugs (e.g., penicillin) where drug binds to cell surface and antibody cause removal of the cells (usually by macrophages).
  • 24. TYPE III IMMUNE COMPLEX MEDIATED REACTIONS ANTIGEN+HUMORAL ANTIBODIES IMMUNE COMPLEXES Ab EXCESS Ppt.NEAR SITE OF ENTRY SKIN-ERYTHEMA,EDEMA, ETC. ARTHUS REACTION Ag EXCESS DEPOSIT IN SKIN, JOINTS KIDNEY SERUM SICKNESS
  • 25. Arthus Reaction: acute antibodymediated hypersensitivity to soluble antigens
  • 26. TYPE IV CELL MEDIATED REACTION-(Delayed hypersensitivity)  Inflammatory reaction initiated by T cells.  Delayed-secondary cellular response occurs after 48 hrs of antigen exposure.  Examples1.montoux reaction-i.d. tuberculin inj. 2.Sulphonamides
  • 27. Four Types of Hypersensitivities
  • 28. MANIFESTATION OF ADR 1. Haemopoetic toxicity 2. Hepatotoxicity –direct / immunological 3. Nephrotoxicity 4. Abnormality in taste & smell 5. Occular toxicity 6. Ototoxicity 7. Behavioural toxicity 8. Iatrogenic diseases 9.Teratogenicity
  • 29. Risk Factors for Adverse Drug Reactions Simultaneous use of several different drugs – Drug-drug interactions Very young, or very old in age Pregnancy Breast Feeding Hereditary Factors Disease states which may effect drug absorption, metabolism, and/or elimination 32
  • 30. Risk Factors Examples: Simultaneous Drug Use or Drug-Drug Interactions Cerivastatin-Gemfibrozil interactions in hypercholesterolemia patients (rhabdomyolysis) Coumadin-NSAID interactions (increased inhibition of platelet aggregation) Venlafaxine-indinavir interactions in depressed HIVinfected patients (decreased indinavir concentrations) 33
  • 31. Risk Factors Examples: Age Related Issues Children are often at risk because their capacity to metabolize drugs is usually not fully developed – Newborns cannot metabolize or eliminate chloramphenicol, an antibiotic – Children younger than 18 may be at risk of developing Reye’s syndrome if given acetylsalicylic acid (aspirin) while infected with chickenpox or influenza – Central nervous system effects of topiramate in children (seizures, tremor, and dizziness) 34
  • 32. Risk Factors Examples: Age Related Issues ïŹ ADRs, including drug interactions, are a common cause of admission to hospitals in the elderly ïŹ Reasons for ADRs in the elderly: – Concomitant use of several medications – Disease states leading to drug ADME changes – Decreased drug ADME activity due to age ïŹ These conditions are exacerbated by malnutrition and dehydration, common in the elderly 35
  • 33. Risk Factors Examples: Pregnancy ïŹ Use of sulfonamides (antibiotic) can lead to jaundice and brain damage in the fetus ïŹ Warfarin use for anticoagulation can lead to birth defects, and increased risk of bleeding problems in newborns and mothers ïŹ Lithium, for bipolar disorder, can lead to defects of the heart, lethargy, reduced muscle tone, and underactivity of the thyroid gland 36
  • 34. Risk Factors Examples: Breastfeeding ïŹ Similar concerns, as for other children with underdeveloped capability to metabolize or excrete xenobiotics ïŹ Many drugs can be passed from mother to infant via breast milk – Amantadine (antiviral) – Cyclophosphamide (antineoplastic) – Cocaine (Schedule 2 FDA drug) – Carisoprodol (skeletal muscle relaxant) 37
  • 35. Risk Factors Examples: Hereditary Factors ïŹ Genetic polymorphisms may play a role – Evident in CYP2C9 and 2C19, especially in the Asian population (phenytoin) – May lead to impaired metabolism in mutation of enzymes ïŹ Higher risk of hemolysis in some populations, such as African, Middle Eastern, and South East Asian races – Quinolones – Antimalarials 38
  • 36. Risk Factors Examples: Disease States ïŹ Metabolism (Phase I or II) may be impaired with hepatic disease – Cirrhosis – Hepatic Carcinoma ïŹ Renal Insufficiency – Acute or Chronic Renal Failure – Decreased glomerular filtration rate (GFR) ïŹ Drug levels may become toxic if too high, so dosing modifications may be indicated 39

Hinweis der Redaktion

  1. igen
  2. Make comment about diphenhydramine and sedation (positive outcome) Also about retonovir and ropenivir (retonovir increases concentrations of ropenivir, resulting in higher drug concentrations = lower doses)
  3. Thalidomide example for risk in pregnancy (resulted in severe birth defects). Now used in the treatment of multiple myeloma, although efficacy not fully established